Australian males aged 18+ years are being sought to participate in an online survey about their knowledge of their reproductive health and male fertility.
Contact: Brooke Norris or Dr Melissa Oxlad (School of Psychology)
Identifying the most appropriate bone scan strategy for Australian men with prostate cancer
Hiwase MD, Jay A, Bulamu N, Teh J, Paterson F, Kichenadasse G, Vincent AD, O'Callaghan M; South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC). Prostate Cancer Prostatic Dis. 2022 Mar 14. doi: 10.1038/s41391-022-00515-8.
Contact: Andrew Vincent
"She'll Be Right, Mate": A Mixed Methods Analysis of Skin Cancer Prevention Practices among Australian Farmers-An At-Risk Group
"She'll Be Right, Mate": A Mixed Methods Analysis of Skin Cancer Prevention Practices among Australian Farmers-An At-Risk Group. Trenerry C, Fletcher C, Wilson C, Gunn K. Int J Environ Res Public Health. 2022 Mar 3;19(5):2940. doi: 10.3390/ijerph19052940.
Contact: Kate Gunn
Testosterone, Diabetes Risk, and Diabetes Prevention in Men
Testosterone, Diabetes Risk, and Diabetes Prevention in Men. Yeap BB, Wittert GA. Endocrinol Metab Clin North Am. 2022 Mar;51(1):157-172. doi: 10.1016/j.ecl.2021.11.004. Epub 2022 Feb 8. PMID: 35216714.
Contact: Gary Wittert
Fatty acid oxidation inhibition to treat advanced prostate cancer
With progressed prostate cancer, men are no longer responding to the standard anti-androgen drug therapy. While developing new drugs often can take 15 years, this program will reduce this timeframe by aiming to re-purpose existing lipid-modifying medicines. We aim to take our laboratory findings into a proof-of-concept clinical trial to test whether trimetazidine is safe and effective in treating men on ADT, to prevent or delay the onset of lethal castrate resistant prostate cancer.
Through this trial we aim for a potential new therapeutic approach using existing drugs used to treat cardio-metabolic disease to prevent lethal prostate cancer, reduced drug-related toxicities in men being treated for prostate cancer, and Improved length and quality of life for men living with advanced prostate cancer.
Contact: Dr Zeyad Nassar
Improving precision medicine for men being treated for prostate cancer
The aim of this project is to determine the impact of commonly prescribed classes of concomitant non-cancer medicines (i.e.antibiotics, proton pump inhibitors, lipid- and blood glucose-lowering medications) on the efficacy of treatments for metastatic prostate cancer. To achieve this, we will exploit large clinical trial datasets, sophisticated data analytic methods (e.g. machine learning) and biologically-informed models.
Contact: Dr Ashley Hopkins
Digitally driven pathways to optimise use and outcomes of primary care for men
This research aims to translate the Centre’s research into an impactful health service integration program targeting the patient-GP interface, arming men with the knowledge, motivation, and agency to recognize symptoms and health behaviours as prompts to engage with primary health care services, and providing men and GPs with tools that optimise the outcomes of that engagement.
Contact: Professor Gary Wittert
Improving uptake of prostate cancer screening in men from culturally and linguistically diverse backgrounds.
We will partner with researchers and community outreach officers at Cancer Council SA (lead by Dr Jess Loyer), the Multicultural Communities of South Australia Men’s Group who are investigating barriers to engagement with cancer control programs among CALD communities.
This program aims to adapt the current RACGP prostate cancer screening decision-making tool to be culturally sensitive and meet the needs of men from CALD backgrounds and improve the uptake of PSA screening which will facilitate early detection and treatment/monitoring of prostate cancer.
Contact: Dr Norma Bulamu
Clinical workforce development: Healthy Male-Bellberry Clinical Training Fellowship in Men’s Health
This program is a 1-year South-Australian-based clinical training fellowship in andrology and Men’s Health, delivered in association with Healthy Male (Andrology Australia) to develop a dedicated men’s health clinical sub-specialty workforce and services.
Contact: Professor Gary Wittert
Extending the Male Depression Risk Scale for use with older men
Extending the Male Depression Risk Scale for use with older men: the effect of age on factor structure and associations with psychological distress and history of depression.
Herreen D, Rice S, Ward L, Zajac I. Aging & Mental Health 2021. DOI: 10.1080/13607863.2021.1947966
Contact: Danielle Herreen
Strengthening Men’s Health Promotion in Australia
Strengthening men’s health promotion in Australia: Poole, G., Smith, J. & Gupta, G. Health Promotion Journal of Australia..
Contact: James Smith
Men needed for study comparing outcomes of team-sport versus circuit training based exercise programs
Men aged 35–54 years, who are not currently playing team-sport, are invited to take part in a 12-week (2x per week) exercise program (Australian Rules Football or circuit-based training) at the University of South Australia Mawson Lakes campus and undergo some health testing.
Contact: UniSA research or Ph. 8302 1365.
FCMHW-NT partners with MOVEMBER to support social connectedness of young Indigenous males
MEDIA RELEASE: Boost for male health as Flinders University joins the FCMHW research alliance
Lancet letter calls for greater intersectionality within men’s health to advance the discipline
Implications of critical race theory for Aboriginal and Torres Strait Islander men's health.
Merlino A, Canuto K, Smith JA. Lancet Glob Health. 2021 Jun;9(6):e756. doi: 10.1016/S2214-109X(21)00100-5.
PMID: 34019832
Contact: Kootsy Canuto